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Eben Donges Hospital (EDH) is a regional hospital in the
Boland/Overberg region of the Western Cape. It serves a
diverse community whose economic stability is reliant on the
intensive fruit-farming industry.  This farming is heavily
dependent on organophosphate (OP)-containing insecticides
for pest control, often to the detriment of labourers’ health.
The combination of accessibility, limited legislation and lack of
education has resulted in frequent OP exposure, including
among children.
Acetylcholine, the neurotransmitter at postganglionic
parasympathetic, preganglionic sympathetic and
parasympathetic, somatic striated skeletal and central nervous
system (CNS) receptors, is rapidly hydrolysed by an enzyme in
the synaptic cleft, acetylcholinesterase.1 OP compounds form
covalent bonds with the latter resulting in an excess of
acetylcholine, which produces hyperstimulation and the
myriad of symptoms and signs characteristic of
organophosphate poisoning (OPP).2-6
Anticholinergics, in particular atropine, have been the
cornerstone of OPP treatment for decades.7 Atropine’s role as a
competitive antagonist at the muscarinic receptors in the
peripheral and CNS allows rapid control of the bradycardia,
hypotension, bronchospasm, excessive secretions and
gastrointestinal complications of OPP, allowing for stabilisation
of the patient.3 Atropine does not reverse the effects of OPP at
the nicotinic and all CNS receptors and patients may require
additional support for respiratory muscle paralysis/weakness
and convulsions, etc.3
Atropine’s biochemical structure allows it to pass through
the blood-brain barrier, potentially reversing some of the CNS
effects of the OPP; however it can also produce symptoms
indistinguishable from the very condition the clinician is trying
to treat, namely nervousness, drowsiness, mental confusion
and agitation.  These symptoms appear to be dose related and
are a complication of treating OPP.5
Currently there is no literature documenting the incidence of
CNS atropine toxicity in children during OPP treatment.
Objectives
The study aimed to document the presentation and course of
OPP among children treated for this condition and to record
the frequency of CNS atropine toxicity. 
Method
A retrospective folder review was undertaken of all paediatric
patients (age 12 years and younger) admitted to EDH with
confirmed OPP over a 5-year period from 1 June 1996 to 31
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Objectives. To document the presentation and course of
organophosphate poisoning (OPP) in children and to record
the frequency of atropine toxicity during treatment. 
Design. A retrospective observational study was conducted of
all recorded paediatric cases of OPP admitted to a regional
hospital over a 5-year period from 1 June 1996 to 31 May 2001.
Setting. The study was conducted at Eben Donges Hospital, a
regional hospital in the Boland/Overberg area of the Western
Cape, where pesticide-intensive fruit farming remains the
largest revenue generator.
Subjects. The study included all children aged 12 years or less
(as per health services classification) with confirmed OPP.
Results. There were 23 patients. Most of the cases came from
the De Doorns area (35%), with poisoning by ingestion
accounting for 61% of cases. A distinct seasonal predominance
was found that coincided with the summer harvest. Mode of
presentation was variable and was not related to the initial
pseudocholinesterase level. Evidence of atropine toxicity
occurred in 8 of the 18 cases treated with atropine. No
statistically significant risk factor was found for atropine
toxicity. The average duration of hospitalisation was 5.05 days,
with 2 children requiring transfer to tertiary facilities.
Conclusions. The high number of referrals from a specific
geographical area, combined with a 61% accidental ingestion
rate, illustrates an area where legislation has failed to limit
unnecessary exposure. Awareness of the seasonal
predominance could prove pivotal to the success of future
preventive strategies.  Initial presentation and serum
pseudocholinesterase levels did not correlate with duration of
stay. The decision to transfer to a tertiary facility should only
be explored once the patient has been stabilised with atropine.
Atropine treatment is effective but carries a risk of toxicity.
Glycopyrrolate may constitute an alternative treatment option.
S Afr Med J 2005; 95: 678-681.
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May 2001.  The diagnosis of OPP was based on a combination
of history of suspected poisoning, presenting symptoms and
signs (Table I) and definitive confirmation using serum
pseudocholinesterase levels.  Participants’ folders were
reviewed for data on age, sex, geographical district/area of
exposure to poison, presenting symptoms and signs,
pseudocholinesterase level, mode of treatment, duration of
hospital stay and documented evidence of CNS atropine
toxicity.  Atropine toxicity was defined as the persistence of
symptoms of excessive nervousness, drowsiness, mental
confusion, agitation or excitement after 24 hours in a child with
dilated pupils and a clear record of repeated doses of atropine
administration; once documented special investigations
excluded mimicking conditions such as repoisoning with OP
from fat stores and septicaemia. Folders with incomplete data
and uncertain cases were excluded from the review.
This study has the potential to improve preventive strategies
and community awareness of the OPP problem.
Statistical analysis
Categorical variables were compared using the Fisher’s exact
test, and groups were compared using the Mann-Whitney U-
test.  A level of significance of less than 0.05 was used
throughout.
Results
During the study period 23 paediatric patients were treated for
OPP at EDH.  The demographics of these patients showed a
male-to-female ratio of 12:11, with a median age of 4 years and
a range of 1 - 12 years. Children from the De Doorns area in the
Hexriver Valley accounted for 35% (N = 8) of poisonings,
children from Worcester for 17% (N = 4), Breërivier and
Robertson for 9% (N = 2) each respectively, and the remaining
drainage areas had incidental cases.  The documented sources
of poisoning were as follows: 61% (N = 14) accidental ingestion
of OPs, with unwashed freshly sprayed fruit or poorly marked
storage containers as possible sources, 22% (N = 5) skin and
inhalation exposure as a result of recent use of OPs for pest
control in and around homes, and 17% (N = 4) unknown or
unconfirmed source of poisoning.  There appeared to be a
definite seasonal predominance, with cases peaking between
October and January, accounting for 70% (N = 16) of all cases
(Fig. 1).
Presenting symptoms and signs were in keeping with those
described by other authors, with abnormal pupils (78%) and
excessive secretions (65%) the most common features 
(Table II).7
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Table I. Symptoms and signs of organophosphate
poisoning
Muscarinic effects
Cardiovascular system: bradycardia and hypotension
Gastrointestinal tract: salivation, nausea and vomiting,
diarrhoea and abdominal pain, tenesmus and faecal
incontinence
Respiratory system: bronchospasm, bronchorrhea
Eyes: miosis
Other: lacrimation, diaphoresis and urination
Nicotinic effects
Musculoskeletal: fasciculation, weakness, paralysis,
cramps and respiratory paralysis
Cardiovascular system: tachycardia and hypertension
Central nervous system effects
Altered level of consciousness, agitation and confusion,
delirium, coma, seizures, ataxia, dysarthria and
respiratory depression
Table II. Summary of presenting symptoms and signs
N (%)
Pin-point pupils 18 (78)
Excessive secretions 15 (65)






Respiratory failure 3 (13)
Apathy 3 (13)
Muscle weakness 2 (8)
Shock 2 (8)
Abdominal pain 2 (8)
‘Garlic’ odour 2 (8)
Irritability 1 (4)
Ingestion of poison 14 (61)
Skin and inhalation exposure 5 (22)
Unknown source of poisoning 4 (17)
Fig. 1. Seasonal OPP incidence.
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All patients admitted were treated in the same way. Initial
conservative therapy included gastric lavage and use of
activated charcoal (for suspected ingestion cases), declothing
and full-body wash, and cardiovascular and respiratory
stabilisation. A single dose of obidoxime, a cholinesterase
reactivator, was used in 9 cases on admission.  Of the 23 cases,
20 received atropine (according to the recommended OPP
dosage), 2 treated conservatively and 1 case received a
glycopyrrolate (Robinul) infusion (Fig. 2). 
Intubation was required in 4 children, of whom 2 received
short-term (less than 24 hours) ventilation.  The remaining 2
children were transferred to a tertiary facility, 1 for intractable
seizures not controllable with conventional anticonvulsants
and requiring a Thiopentone infusion, and the other for
hypoxic cerebral damage from respiratory failure and
cardiovascular collapse.  The former child survived with
neurological impairment and the latter died 10 days after
presentation.
Documented evidence of CNS atropine toxicity occurred in 8
of the 18 cases (excluding the 2 transferred patients) treated
with atropine, equivocating to 44% of cases. No statistically
significant difference could be found when comparing patients
with atropine toxicity and those without toxicity (Table III). 
There was also no correlation between pseudocholinesterase
levels and duration of stay, as shown in Fig 3.
Discussion
The liberal use of pesticides in the agriculturally rich region of
the Western Cape has contributed significantly to the ever-
increasing number of reported poisonings in this region.
Pesticide poisoning in children under 14 years of age has a
reported average incidence of 0.367/100 000. OPP accounts for
49.9% of all poisonings.8 OPP is a notifiable disease in South
Africa and it can be assumed that the reported numbers are a
gross underestimation of the real problem.9 Our study region is
well represented in the above statistic. 
The seasonal predominance between October and January is
an overriding feature of these poisonings. The fact that
incidence coincides with peak spraying activities (a trend also
noted by other authors) could prove pivotal to the success of
future preventive strategies.10 OPP indicates a problem of
increased exposure to and circulation of agricultural pesticides.
More stringent enforcement of current legislation is required,
along with a need for education.  Education of both employees
and employers cannot be overemphasised, as this remains
pivotal in reducing exposure to these hazardous chemicals,
especially among children. Legislation forcing farms to erect
clear signage warning children and adults to keep away from
recently sprayed areas may be an effective solution. School-
based programmes (as attempted by the Department of Health
a few years ago) and child-to-child programmes should be
introduced. The high number of referrals from the De Doorns
area (35%) in combination with 61% of poisonings by
accidental ingestion indicates a high-risk area that would
benefit from a structured education programme.  Legislation,
particularly in the De Doorns area, should be more strictly
enforced, with seasonal air monitoring, more stringent control
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Table III. Comparison of atropine toxicity groups (standard
deviation)
Patient data Atropine toxicity No atropine toxicity
Age (yrs) 5.38 (3.623) 3.5 (2.415)
Duration of hospital 
stay (days) 4.82 (0.99) 4.9 (1.75)
Pseudocholin-
esterase level (IU) 563.1 (285.6) 425.2 (401.8)
Ingestion of poison 5 4
Inhalation and skin
exposure 2 3
Unknown source of 
poisoning 7 7
Fig. 2. Treatment summary.
Fig. 3. Scatter plot of pseudocholinesterase level v. duration of stay.
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of pesticide storage and regular/random blood levels done on
employees.
Diversity in mode of presentation was the result of the
population having access to a variety of OP-containing
insecticides of varying concentration, and of delay in
presentation because of the large patient drainage area.
Atropine is without doubt extremely effective for rapid
stabilisation of these patients, but its side-effects and high risk
of toxicity should be criticised. All patients in our study group
were treated according to recommended OPP treatment
protocols regarding dosage, monitoring and weaning from
atropine; despite these guidelines toxicity was recorded in 44%
of cases. When assessing age, pseudocholinesterase levels, or
mode of poisoning as risk factors for atropine toxicity, no
independent risk factor could be identified.
Possible reasons for the high rate of toxicity include a poor
definition of atropine toxity that resulted in an overestimation
of cases, small sample size, or physicians erroneously
attributing symptoms/signs to OPP, and therefore increasing
atropine dosage.  
EDH functions as a regional hospital, with ventilatory
facilities limited to short-term (less than 48-hour) stabilisation
of children before transfer to a tertiary facility. Ventilatory
support was provided for 4 patients. Ingestion was sighted as
the source of poisoning in both the transferred patients,
possibly implying a higher dosage of OP but correlated poorly
with the serum pseudocholinesterase level.  The
symptomatology for the 4 ventilated patients showed marked
variability, accentuating the multifactorial influences governing
OPP. The only overlapping trend was hypoxia and copious
secretions cited as the indication for intubation in 3 of the
cases.   In our experience pseudocholinesterase correlated
poorly with regard to severity of poisoning, based on duration
of stay and clinical response to treatment. Some children with
levels below 300 international units (IU) had a brief
uncomplicated stay and others with levels in excess of 1 000 IU
had a prolonged stay even requiring intubation.   The decision
to transfer to a tertiary facility should only be explored once
the patient has been stabilised with atropine, as the response
may be rapid and warrants regular reassessment. 
One patient received glycopyrrolate. Recent advances in the
field of anticholinergics have generated renewed interest in
glycopyrrolate, particularly its potential for managing OPP.
Drugs such as glycopyrrolate and scopolamine are used
extensively in anaesthesiology as alternatives to atropine.
Glycopyrrolate, a quaternary amine, penetrates biological
membranes, especially the blood-brain barrier, slowly; this
pharmacokinetic distinction from atropine has resulted in a
number of studies comparing the use of glycopyrrolate and
atropine in OPP.4,11,12 One study performed on adults found no
particular difference in outcome between the 2 drugs but found
a statistically significant decrease in bronchial secretions in
those treated with glycopyrrolate.4 The study also commented
on glycopyrrolate’s potential to distinguish atropine toxicity
from conditions that mimic it such as repoisoning with OP and
septicaemia.4 Compared to atropine its side-effect profile is also
considerably better. There are fewer tachycardias; potential
central nervous system effects such as headaches, insomnia,
nervousness, etc. are unlikely owing to poor blood-brain
barrier penetration; while xerostomia, loss of taste, decreased
sweating and urticaria are similar to atropine. However
glycopyrrolate enhances gastro-oesophageal reflux and has the
potential to cause muscle weakness.11
The study has a number of shortcomings. The fact that it was
a retrospective folder review with a small sample size limits
the conclusions that can be drawn. For the most part the
sample group is derived from a predictable population, at high
risk of exposure or previous exposure, which could have
affected response to standard treatment protocols. The high
number of referrals from the De Doorns area may represent
artefactual results due to a high index of suspicion, proximity
to EDH, and other OPP cases draining to outlying hospitals.
There was a small peak of cases during June because 2 siblings
presented to EDH after an OP for pest control had been used
inside their home. The use of obidoxime may perpetuate
atropine toxicity but is unlikely with single-dose
administration. Pseudocholinesterase is not specific for OPP
alone but is also decreased in organocarbamate poisoning.13
Clearly defining the terms ‘atropine toxity’ and ‘poor
prognosis’ is troublesome.
OPP is a reality, with serious consequences; however the
high risk of atropine toxicity during treatment may potentially
be even more detrimental to the child, masking sepsis or
repoisoning. Regular re-evaluation is essential.
References
1. Mortensen ML. Management of acute childhood poisonings caused by selected insecticides
and herbicides. Paediatr Clin North Am 1986; 33: 421 - 442.
2. Reigart JR, Roberts JR. Environmental Protection Agency: Recognition and Management of
Pesticide Poisoning. 5th ed. 4: 34–47.
3. Bardin PG, van Eeden SF, Moolman JA, Foden AP, Joubert JR.  Organophosphate and
carbamate poisoning.  Arch Intern Med 1994; 154: 1433 – 1441.
4. du Toit PW, Muller FO, van Tonder WM, Ungerer MJ. Experience with the intensive care
management of organophosphate insecticide poisoning.  S Afri Med J 1981; 60: 227 - 229.
5. Bardin PG, Eeden SF.  Organophosphate poisoning: Grading the severity and comparing
treatment between atropine and glycopyrrolate. Crit Care Med 1990; 18: 956 - 959.
6. Lund C, Monteagudo FSE.  Early management of organophosphate poisoning. S Afr Med J
1986; 69: 6.
7. Hayes MM, van der Westhuizen NG, Gelfand G.  Organophosphate poisoning in Rhodesia. S
Afr Med J 1978; 54: 230 – 234.
8. London L, Rother H.  Pesticidal poisoning in South Africa, 1980 - 1994. Epidemiological
Comments 1995; 22: 112-138.
9. London L, Ehrlich RI, Rafudien S, Krige F, Vurgarellis P. Notification of pesticide poisoning
in the Western Cape, 198 –1991. S Afr Med J 1994 84: 269 - 272. 
10. Innes DF, Fuller BH, Berger GMB.  Low serum cholinesterase levels in rural workers exposed
to organophosphate pesticide sprays.  S Afr Med J 1990; 78: 581 – 583.
11. Glycopyrrolate.  Drugdex Drug Evaluation. 108: 1.4.1 – 3.3.12 
12. Tracey JA, Gallagher H. Use of glycopyrrolate and atropine in acute organophosphate
poisoning. Hum Exp Toxicol 1990; 9: 99-100.
13. Rotenberg M, Shefi M, Dany S, Dore I, Tirosh M, Almog S.  Differentiation between
organophosphate and carbamate poisoning. Clin Chim Acta 1995; 234: 11 – 12.
Accepted 24 June 2005.
681
September 2005, Vol. 95, No. 9  SAMJ
Pg 678-681 spot  9/7/05  9:26 AM  Page 681
